JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 2, 2007; DOI: 10.1124/jpet.106.117507


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.117507v1
321/3/1054    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moya, P. R.
Right arrow Articles by Clarke, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moya, P. R.
Right arrow Articles by Clarke, W. P.


Received for publication December 1, 2006.
Revised February 28, 2007.
Accepted for publication February 28, 2007.

Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-HT2A and 5-HT2C Receptors

Pablo R. Moya 1, Kelly A. Berg 2, Manuel A. Gutierrez-Hernandez 3, Patricio Saez-Briones 3, Miguel Reyes-Parada 3, Bruce K. Cassels 3, William P. Clarke 2*

1 University of Chile 2 University of Texas Health Science Center 3 Univeristy of Chile

* Address correspondence to: E-mail: clarkew{at}uthscsa.edu

Abstract

2,5-dimethoxy-4-substituted phenylisopropylamines and phenethylamines are serotonin2A/2C (5-HT2A/2C) agonists. The former are partial to full agonists, whereas the latter are partial to weak agonists. However, most data come from studies analyzing phospholipase C (PLC)-mediated responses, although additional effectors (e.g. phospholipase A2 (PLA2)) are associated with these receptors. We compared two homologous series of phenylisopropylamines and phenethylamines measuring both PLA2 and PLC responses in CHO-K1 cells expressing human 5-HT2A or 5 HT2C receptors. Also, we assayed both groups of compounds as head shake inducers in rats. At the 5-HT2C receptor, most compounds were partial agonists for both pathways. Relative efficacy of some phenylisopropylamines was higher for both responses as compared to their phenethylamine counterparts, whereas for others, no differences were found. At the 5-HT2A receptor, most compounds behaved as partial agonists, but unlike findings at 5-HT2C receptor, all phenylisopropylamines were more efficacious than their phenethylamine counterparts. 2,5-DMA (2,5-dimethoxyphenylisopropylamine) activated only the PLC pathway at both receptor subtypes, 2C-H (2,5-dimethoxyphenethylamine) was selective for PLC at the 5-HT2C receptor, and 2C-N (2,5-dimethoxy-4-nitrophenethylamine) was PLA2-specific at the 5-HT2A receptor. For both receptors, the compounds' rank order of efficacy differed depending upon which response was measured. The phenylisopropylamines were strong head shake inducers, whereas their phenethylamine congeners were not, in agreement with in vitro results and the involvement of 5-HT2A receptors in the head shake response. Our results support the concept of functional selectivity and indicate that subtle changes in ligand structure can result in significant differences in the cellular signaling profile.


Key words: efficacy, functional selectivity, hallucinogens, serotonin receptors, signal transduction, stimulus trafficking


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. A. Berg, J. Dunlop, T. Sanchez, M. Silva, and W. P. Clarke
A Conservative, Single-Amino Acid Substitution in the Second Cytoplasmic Domain of the Human Serotonin2C Receptor Alters Both Ligand-Dependent and -Independent Receptor Signaling
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1084 - 1092.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.